Viking Therapeutics Shares Fall 5.2% Premarket; Amgen 'encouraged' by Its Weight-Loss Drug Interim Data
Viking Therapeutics股價盤前下跌5.2%;安進受其減肥藥物中期數據感到 “鼓舞”
Viking Therapeutics Shares Fall 5.2% Premarket; Amgen 'encouraged' by Its Weight-Loss Drug Interim Data
Viking Therapeutics股價盤前下跌5.2%;安進受其減肥藥物中期數據感到 “鼓舞”
使用瀏覽器的分享功能,分享給你的好友吧